Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this
Loyal is developing the first longevity drugs for dogs, targeting the underlying processes of aging to increase healthy lifespan. Their lead drug, LOY 002, aims to extend lifespan and maintain quality of life in senior dogs by addressing age-associated metabolic dysfunction.
Parse Score
#58 of 73 in Healthcare Patient Scheduling and Telehealth Software
The market map
Healthcare Patient Scheduling and Telehealth Software →Where AI ranks Loyal